S. No |
Title |
Location |
References |
| 1 | Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia | Mexico | https://clinicaltrials.gov/ct2/show/NCT04381858 |
| 2 | Polyvalent Immunoglobulin in COVID-19 Related ARds | France | https://clinicaltrials.gov/ct2/show/NCT04350580 |
| 3 | Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients | Italy | https://clinicaltrials.gov/ct2/show/NCT04346589 |
| 4 | NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER, COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE | France | https://clinicaltrials.gov/ct2/show/NCT04403269 |
| 5 | Acquiring Convalescent Specimens for COVID-19 Antibodies | United States | https://clinicaltrials.gov/ct2/show/NCT04342195 |
| 6 | Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection | Spain | https://clinicaltrials.gov/ct2/show/NCT04366245 |
| 7 | Convalescent Plasma for COVID-19 Close Contacts | United States | https://clinicaltrials.gov/ct2/show/NCT04390503 |
| 8 | Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study) | Netherlands | https://clinicaltrials.gov/ct2/show/NCT04342182 |
| 9 | Convalescent Plasma Therapy in Patients With COVID-19 | Indonesia | https://clinicaltrials.gov/ct2/show/NCT04407208 |
| 10 | Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients | India | https://clinicaltrials.gov/ct2/show/NCT04346446 |
| 11 | Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19 | Saudi Arabia | https://clinicaltrials.gov/ct2/show/NCT04347681 |
| 12 | Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial | Spain | https://clinicaltrials.gov/ct2/show/NCT04374539 |
| 13 | Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection | Greece | https://clinicaltrials.gov/ct2/show/NCT04408209 |
| 14 | Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression | Italy | https://clinicaltrials.gov/ct2/show/NCT04374526 |
| 15 | Convalescent Plasma Therapy in Severe COVID-19 Infection | Bangladesh | https://clinicaltrials.gov/ct2/show/NCT04403477 |
| 16 | Transfusion of Convalescent Plasma for the Early Treatment of Patients With COVID-19 | Italy | https://clinicaltrials.gov/ct2/show/NCT04393727 |
| 17 | Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial | Mexico | https://clinicaltrials.gov/ct2/show/NCT04405310 |
| 18 | CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1) | Canada | https://clinicaltrials.gov/ct2/show/NCT04348656 |
| 19 | COVID-19 Plasma Collection | United States | https://clinicaltrials.gov/ct2/show/NCT04344015 |
| 20 | COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma | Mexico | https://clinicaltrials.gov/ct2/show/NCT04357106 |
| 21 | Plasma Therapy of COVID-19 in Critically Ill Patients | United States | https://clinicaltrials.gov/ct2/show/NCT04359810 |
| 22 | Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia | Mexico | https://clinicaltrials.gov/ct2/show/NCT04358783 |
| 23 | Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients | United States | https://clinicaltrials.gov/ct2/show/NCT04364737 |
| 24 | Passive Immunity Trial of Nashville II for COVID-19 | United States | https://clinicaltrials.gov/ct2/show/NCT04362176 |
| 25 | Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19 | Switzerland | https://clinicaltrials.gov/ct2/show/NCT04389944 |
| 26 | COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID) | Chile | https://clinicaltrials.gov/ct2/show/NCT04384588 |
| 27 | Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study | Sweden | https://clinicaltrials.gov/ct2/show/NCT04384497 |
| 28 | Convalescent Plasma Therapy vs. SOC for the Treatment of COVID19 in Hospitalized Patients | Spain | https://clinicaltrials.gov/ct2/show/NCT04345523 |
| 29 | Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease | Russia | https://clinicaltrials.gov/ct2/show/NCT04392414 |
| 30 | Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia | United States | https://clinicaltrials.gov/ct2/show/NCT04374565 |
| 31 | Hyperimmune Plasma in Patients With COVID-19 Severe Infection | Italy | https://clinicaltrials.gov/ct2/show/NCT04385043 |
